Long-term treatment with 12-O-tetradecanoylphorbol 13-acetate (TPA) down-regulates select protein kinase C (PKC) isozymes and may differentially affect PKC substrates. We investigated the role of PKC down-regulation on phosphorylation of two PKC substrates, the 43 kDa growth-associated protein (GAP-43) and the myristoylated alanine-rich C-kinase substrate (MARCKS) in SK-N-SH human neuroblastoma cells. Cells were treated with 70 nM TPA for 15 min, 17 or 72 h. Phosphorylation of MARCKS and GAP-43 was elevated throughout 72 h of TPA. The magnitude and peptidic sites of phosphorylation in GAP-43 and MARCKS were similar after all TPA treatments. GAP-43, but not MARCKS, content was increased after 17 and 72 h of TPA. The ratio of GAP-43 phosphorylation to content was elevated throughout 17 h but returned to control by 72 h as content increased. PKC O and K isozyme content was greatly reduced after 72 h of TPA but membranes retained 23% of PKC activity. Only PKC O translocated to membranes after 15 min TPA. GAP-43 content after 72 h of TPA was increased in subcellular fractions in which significant PKC O isozyme concentration remained. These results demonstrate that continuous TPA differentially affected phosphorylation of PKC substrate proteins and regulation of PKC isozyme content in SK-N-SH cells. ß
Introduction
The protein kinase C (PKC) family of serine/threonine protein kinases contains at least eleven isozymes that are classi¢ed into three or four subgroups (for reviews see [28, 33] ). The classical PKC isozymes are activated by Ca 2 and diacylglycerol; the Ca 2 -independent novel PKCs are activated by phospholipid alone and the Ca 2 -and diacylglycerol-independent, atypical PKCs and PKC W are activated by as yet undetermined mechanisms. The tumor-promoting phorbol esters, which structurally resemble diacylglycerol, activate classical and novel PKC isozymes but do so at basal intracellular Ca 2 levels ([Ca 2 ] i ) [50] . 12-O-Tetradecanoylphorbol 13-acetate (TPA) initially binds to PKC in the cytosol, whereupon the enzyme translocates to membranes where it can be proteolytically cleaved [22] . Initial proteolytic cleavage may lead to a constitutive, activator-independent protein kinase [9, 49] . Long-term treatment (10^72 h) of intact cells with phorbol esters decreases phorbol ester binding, PKC activity and PKC immunoreactivity to very low levels [28] due to proteolysis of isozymes by calpain [32] and serine proteases [12, 28] . PKC isozymes that do not bind phorbol esters or diacylglycerol are not down-regulated by persistent phorbol ester treatment [28] . Continuous TPA, however, selectively down-regulates the PKC isozymes; those that are most a¡ected depend upon the cell type [9, 22, 28] . Long-term treatment of some cell types with TPA leads to di¡erentiation of the cells [5, 39] .
In some cells, there appears to be a dichotomy between the profound down-regulation of PKC activity and the persistent elevation of phosphate content in a PKC substrate protein. Continuous treatment of human neuroblastoma cells [38] and human astrocytoma cells [5] with TPA down-regulated the PKC activity or isozyme content yet phosphorylation of the prominent PKC substrate, myristoylated alanine-rich C-kinase substrate (MARCKS), remained enhanced. The MARCKS protein is a ubiquitously expressed predominantly membrane-associated protein that has been postulated to play a role in a number of cellular processes including secretion and membrane tra¤cking, cell motility, regulation of the cell cycle, and transformation (for reviews see [1, 6] ). There are at least three phosphorylation sites for PKC on MARCKS, all contained within a 25 amino acid basic sequence [20] . In a previous study, we found that treatment of the human neuroblastoma cell line, SK-N-SH, with TPA for 72 h led to a down-regulation of K and O isozymes of PKC but an enhanced phosphorylation of MARCKS [46] .
Another prominent PKC substrate is the 43 kDa growth-associated protein (GAP-43) (neuromodulin, B50, F1), a neural-speci¢c protein that is phosphorylated by PKC at only one site, serine 41 [2, 14] . GAP-43, also predominantly membrane-bound, is thought to play a role in neuritogenesis, synaptic plasticity and neurotransmitter release (for reviews see [3, 19] ). While it is known that long-term treatment of SH-SY5Y cells with TPA increases GAP-43 mRNA and protein expression [23, 39] , the e¡ect of this treatment on GAP-43 phosphorylation has not been investigated.
The objective of this study was to examine the e¡ect of long-term treatment with TPA on phosphorylation state of GAP-43 in SK-N-SH cells and compare it with the apparently constitutive phosphorylation of MARCKS. Since both are membraneassociated, acid-soluble, PKC substrate proteins that may be involved in similar processes such as cell di¡erentiation, synaptic plasticity and neurotransmitter release, it is of interest to examine whether their phosphorylation is similarly regulated by continuous TPA. If so, this would imply that the physiological actions of phosphorylated forms of these proteins would be prolonged following an extended activation of PKC, where the actions of other PKC substrates might be decreased.
Materials and methods

Materials
Cell culture plasticware was from Costar Scienti¢c (Cambridge, MA). Dulbecco's modi¢ed Eagle's medium (DMEM), fetal bovine serum, penicillin/streptomycin solution, TPA, protein A-Sepharose, pepstatin, leupeptin, phenylmethylsulfonyl £uoride (PMSF), bovine serum albumin, phosphatidylserine, diolein, Staphylococcus aureus V8 protease (SAPV8), 5-bromo-4-chloro-3-indoyl phosphate and nitroblue tetrazolium were purchased from Sigma (St. Louis, MO). [ 32 P] i -Orthophosphoric acid in HCl-free water (8150^9120 Ci/mmol) was purchased from DuPont NEN (Boston, MA). 4K-TPA was purchased from LC Laboratories (Woburn, MA). Ro31-8220 was purchased from Calbiochem (San Diego, CA). Nitrocellulose transfer membranes were from standard suppliers. All other chemicals were of analytical grade.
Cell culture
SK-N-SH human neuroblastoma cells were seeded, grown and harvested as described [29] . Cells were treated with 70 nM TPA in culture medium as described previously [46] . Although the SK-N-SH cell line has been reported to exhibit both neuroblast and epithelial phenotypes [43] , under our culture conditions, i.e. relatively prolonged culture at low initial subculture densities, only the neuroblastoma phenotype is found [44] .
Labeling of cells with [
32 P] i and perchloric acid (PCA) extraction
Incubation of cells with [
32 P] i and isolation of the PCA-soluble fraction ware performed as described [46] . Brie£y, monolayers were washed twice and incubated with 2 ml of phosphate-and serum-free DMEM for 1 h at 37³C. Medium was replaced with 0.5 mCi [
32 P] i in 1 ml phosphate-free DMEM per well and incubated for two more hours. For a 15 min treatment, TPA or vehicle was added directly to the medium as part of the 2 h labeling period. The reaction was stopped by aspirating the medium and washing the monolayers twice with cold Tris-bu¡ered saline (TBS). After TBS removal, cells were extracted with 150^300 Wl of 2.5% perchloric-acid (PCA) containing 150 mM NaCl and 1% Triton X-100 [17] . Extracts were sonicated for 15 min in a water bath sonicator, centrifuged 10 min at 15 000Ug at 4³C, then neutralized with 2 M NaOH. Protein concentration of supernatants (PCA-soluble fraction) was measured using the Pierce BCA protein assay with bovine serum albumin as a standard.
SDS-PAGE and autoradiography
5 Wg of neutralized PCA-soluble protein per treatment was diluted in SDS-sample bu¡er [25] , heated 5 min at 100³C and resolved by SDS-PAGE on 12U14 cm (Hoefer Scienti¢c, San Francisco, CA) gels at 7 or 7.5% polyacrylamide. Gels were soaked in 20% methanol, 5% acetic acid for 30 min, dried on a Bio-Rad gel dryer for 1.5 h at 80³C and exposed to Kodak X-Omat AR ¢lm for 4^24 h. Quantitation using Imagequant software (Molecular Dynamics, Sunnyvale CA) was done after exposing the gels to a phosphor screen for 6^16 h.
Immunoprecipitation of MARCKS and GAP-43 from 32 P i -labeled cells
Immunoprecipitation of MARCKS from 32 P i -labeled cells was performed as described previously [46] , using 10 Wg of neutralized PCA-soluble protein per condition. GAP-43 was immunoprecipitated according to the method of Chapman et al. [11] with the following changes. The bu¡er used throughout the experiment was TEG bu¡er (10 mM TES, pH 7.6, 50 mM NaCl, 4 mM EDTA, 10% glycerol). Neutralized PCA-soluble protein (5 Wg) from 32 P ilabeled cells was precleared with 1 Wg non-immune mouse IgG and 50 Wl of a 20% slurry of protein G-Sepharose in TEG bu¡er (total assay volume 350 Wl) for 1 h at 4³C with rotation. Samples were centrifuged at 15 000Ug for 5 min. Supernatants were removed and added to tubes containing 1 Wg monoclonal anti-GAP-43 (91E12 from Boehringer Mannheim Biochemicals, Indianapolis, IN) and were incubated overnight at 4³C with rotation. A 20% slurry (50 Wl) of protein A-Sepharose was added to each tube and incubation was continued as above for 2 h. The samples were centrifuged as above, the supernatants removed and the immune pellets washed three times with 500 Wl of TEG bu¡er per wash. The ¢nal pellets were resuspended in SDSsample bu¡er and heated 5 min at 100³C. Samples were resolved by electrophoresis on 7% polyacrylamide gels, dried and exposed to ¢lm.
GAP-43 and MARCKS immunoblotting
All incubations were performed at room temperature for 1 h unless otherwise noted. For GAP-43, neutralized PCA-soluble extracts (15^40 Wg) were prepared for SDS-PAGE and resolved by electrophoresis as above. Proteins were transferred to nitrocellulose membranes and blocked with 2% non-fat dry milk in TBS containing 0.1% Tween-20 (TTBS). Membranes were incubated with 0.1 Wg/ml anti-GAP-43 clone 91E12 in blocking bu¡er, washed three times with TTBS, and then incubated with a 1:7500 dilution of goat anti-mouse IgG alkaline phosphatase conjugate (Promega, Madison, WI) in blocking bu¡er and washed again. Immunoreactive proteins were detected with 5-bromo-4-chloro-3-indoyl phosphate and nitroblue tetrazolium as enzyme substrates. Blots were scanned using a Hewlett-Packard ScanJet IIc and density of the bands determined using Imagequant software as described previously. MARCKS immunoblotting was similarly performed except that the blocking bu¡er was 5% non-fat dry milk in TTBS. The primary antibody was polyclonal rabbit anti-human MARCKS (Dr. David Byers, Atlantic Research Center, Nova Scotia, Canada) diluted 1:2000 in blocking bu¡er. The secondary antibody was goat anti-rabbit IgG alkaline phosphatase conjugate (Life Technologies, Grand Island, NY) diluted 1:10 000 in blocking bu¡er.
HPLC analysis of MARCKS tryptic phosphopeptides
PCA-soluble protein (15 Wg) from 32 P i -labeled cells which had been treated with or without TPA was separated by 7% SDS-PAGE and gels were dried and exposed to ¢lm. The bands corresponding to MARCKS were excised and prepared for HPLC according to Blackshear et al. [7] with minor modi¢ca-tions. Brie£y, the excised gel pieces were rehydrated in 10 mM Tris-HCl, pH 7.4, 5 mM MgCl 2 for 51 0 min with several bu¡er changes. Each piece was then cut into smaller pieces with a razor blade, added to 2 ml of the same bu¡er containing 500 Wg of trypsin (N-tosyl-L-phenylalanine chloromethyl ketone-treated) (Sigma, St. Louis, MO) and incubated for 24 h at 37³C with rotation. The samples were centrifuged, washed once with 0.5 ml of Tris-MgCl 2 bu¡er and the supernatants combined and lyophilized. Lyophilized samples were dissolved in a small volume of 0.01% (v/v) tri£uoroacetic acid, and separated on a 2.1 mmU15 cm C4 reverse phase high performance liquid chromatography column (Vydac silica 5 Wm, Phenomenex, Torrance CA) using a gradient of 0^60% (v/v) acetonitrile in 0.1% (v/v) tri£uoroacetic acid at a £ow rate of 0.8 ml/min. Fractions were collected every 30 s and counted on a Beckman Model LS5800 scintillation counter.
SAPV8 protease digestion of 32 P-labeled GAP-43
GAP-43 was immunoprecipitated as above and resolved by electrophoresis on a 7% polyacrylamide gel. After electrophoresis, gels were exposed to ¢lm for 1^2 h. The band corresponding to [ 32 P]-GAP-43 was excised and put in 80 Wl of SDS-sample bu¡er. A 20 Wl volume of SAPV8 in SDS-sample bu¡er was added for a ¢nal amount of 3.3 ng of enzyme per sample. The gel pieces and bu¡er were placed into the bottom of wells of a 15% SDS gel which had a 4% stacking gel of at least 2 cm in length [13] . Electrophoresis was performed overnight at 50 V. Gels were dried and exposed to ¢lm as described earlier.
Protein kinase C isozyme immunoblotting
100 000Ug supernatant and pellet fractions were prepared after homogenizing cells in a bu¡er containing 0.32 M sucrose, 40 mM Tris-HCl, pH 7.4, 1 WM leupeptin, 1 WM pepstatin and 1 mM phenylmethylsulfonyl £uoride. The fractions were resolved by electrophoresis on 7.5% SDS-PAGE gels and transferred to nitrocellulose membranes. Membranes were blocked with 2% non-fat dry milk in TTBS (PKC L was blocked with 3% milk in TTBS) and incubated in blocking bu¡er with monoclonal mouse anti-PKC K (1:500 dilution) (a generous gift from Karen L. Leach, Upjohn Laboratories, Kalamazoo, MI), a¤nity puri¢ed rabbit anti-PKC L (1:500 dilution in TTBS+1% milk) (Life Technologies, Grand Island, NY), or a¤nity puri¢ed rabbit anti-PKC O or j (1:1250 or 1:1000 dilution in blocking bu¡er, respectively) (Life Technologies). After three washes with TTBS, membranes were incubated either with goat anti-mouse IgG alkaline phosphatase conjugate (1:7500 in blocking bu¡er; Promega) for PKC K, or goat anti-rabbit IgG alkaline phosphatase (Life Technologies) for PKC O and j (1:10 000 in blocking bu¡er) and PKC L (1:10 000 in TTBS+0.5% non-fat dry milk). Blots were washed and immunoreactive proteins detected with 5-bromo-4-chloro-3-indoyl phosphate and nitroblue tetrazolium.
Measurement of PKC activity
Cells were grown and treated in 35 mm cell culture plates with TPA for the indicated times. The medium was removed by aspiration and the monolayers were washed twice with cold TBS. The TBS was removed and 200 Wl of cold lysis bu¡er (10 mM Tris-HCl, pH 7.4, 10 mM MgCl 2 , 150 mM NaCl, 1 mM L-mercaptoethanol, 10 WM leupeptin, 10 WM pepstatin and 1 mM PMSF) was added to each well. Cells were incubated for 2 min at room temperature prior to collection with a cell scraper and sonication for 10 s. Lysates were then centrifuged at 100 000Ug for 60 min. Pellets were brought to 1% Triton X-100 in the above bu¡er and incubated at least 30 min on ice prior to a 10-fold dilution into the assay. PKC activity was measured in an assay ( [54] . All radioactivity was measured using L-scintillation counting on a Beckman LS5800.
Subcellular fractionation of SK-N-SH cells
Cells were treated with TPA and harvested as described above. All subsequent steps were performed at 4³C. Cells were homogenized in 40 mM Tris-HCl, pH 7.4, 0.32 M sucrose (Tris-sucrose bu¡er) with 10 strokes of a glass-te£on homogenizer. The homogenate was centrifuged at 1000Ug for 10 min. The pellet was resuspended in the bu¡er, recentrifuged and the resultant pellet (P1) was resuspended in Tris-sucrose bu¡er. The 1000Ug supernatants were combined, centrifuged at 10 000Ug for 20 min and the resultant pellet (P2) was resuspended in Tris-sucrose bu¡er. The 10 000Ug supernatant was centrifuged at 100 000Ug for 60 min to yield a 100 000Ug pellet (P3), which was resuspended in Tris-sucrose bu¡er, and a 100 000Ug supernatant (S3). Samples were used immediately or frozen in liquid nitrogen and stored at 370³C until used for immunoblotting.
Results
E¡ect of 17 or 72 h treatment with TPA on phosphorylation of GAP-43 and MARCKS in SK-N-SH cells
Although our focus is directed to the phosphorylation of GAP-43, we initially investigated the incorporation of [ 32 P] into PCA-soluble extracts of SK-N-SH cells to examine both MARCKS and GAP-43 phosphorylation, and to determine whether other PCA-soluble proteins were a¡ected by this treatment. Cells were treated with vehicle or 70 nM TPA for 17 or 72 h after which 32 P-incorporation into proteins in PCA-soluble extracts was examined. Following pretreatment, the cells were challenged with 70 nM TPA for 15 min. As shown in Fig. 1 , only bands migrating at 86 (p86) and 55 (p55) kDa responded to 15 min of TPA in the vehicle-treated cells, suggesting that they could be PKC substrates. There also appeared to be a protein migrating near 46 kDa that responded to TPA but we were unable to successfully separate out the apparent PKC substrate even when a di¡erent percentage of polyacrylamide was used. The phosphate content of p86 and p55 was increased after cells were treated for 17 and 72 h with 70 nM TPA (Fig. 1) . There was no further response to a 15 min incubation with 70 nM TPA. The level of 32 P-incorporation into these bands after 17 and 72 h of TPA was the same as that attained after 15 min of 70 nM TPA ( Fig. 1 and Table 1 ). Long-term treatment with the inactive phorbol ester 4K-TPA (70 nM) did not elevate p86 or p55 phosphate content at 17 or 72 h (data not shown). Subsequent treatment of 4K-TPA-treated cells with 70 nM of the active form of TPA (4L-TPA) induced 32 P] i for 2 h, treated with 70 nM TPA or 0.1% DMSO vehicle (Ctrl) for 15 min at 37³C and PCA-soluble extracts prepared as described in Section 2. 5 Wg/lane of PCA-soluble protein was separated by 7% SDS-PAGE; gels were dried and exposed to ¢lm. Molecular weight standards (kDa) are indicated to the left.
increased [
32 P]-incorporation into both p86 and p55 (data not shown).
Identi¢cation of GAP-43and MARCKS in the PCA-soluble fraction
We identi¢ed p86 and p55 as MARCKS and GAP-43, respectively, by immunoprecipitating the proteins from the PCA-soluble fraction of 32 P-labeled SK-N-SH cells. Previously, we immunoprecipitated 32 P-labeled MARCKS from 17 and 72 h TPAtreated SK-N-SH cells [46] . To examine basal phosphorylation in untreated cells, the 86 kDa phosphoprotein was immunoprecipitated from both TPAtreated and untreated cells with an antiserum to MARCKS ( Fig. 2A) . A protein migrating at 55 kDa was immunoprecipitated with a monoclonal antibody to GAP-43 (Fig. 2B ). MARCKS contained a basal level of [ 32 P] even in control unstimulated cells but [ 32 P]-GAP-43 was detected only in TPA-treated cells (Fig. 2B) . Only upon long exposure (8^10 days) of the gel to ¢lm could we detect [
32 P]-GAP-43 from untreated cells (see Fig. 5 below) . Phosphorylated and non-phosphorylated GAP-43 were immunoprecipitated equally well by the antibody. 32 P i -Labeled SK-N-SH cells were untreated (3) or treated (+) with 70 nM TPA for 15 min and then (A) 10 Wg of PCA-soluble protein was incubated with a 1:100 dilution of control rabbit serum (serum) or antiserum to MARCKS (Ab) overnight and immune complexes precipitated with protein A-Sepharose as described in Section 2. Immunoprecipitated proteins were separated by SDS-PAGE (8.75% acrylamide), gels were dried and exposed to ¢lm. (B) 5 Wg of precleared PCA-soluble protein was incubated with 1 Wg GAP-43 overnight and immune complexes precipitated with protein G-Sepharose. Immunoprecipitated protein (IP) or PCA-soluble protein (PCA) was separated by SDS-PAGE (7% acrylamide) and gels were dried and exposed to ¢lm. Molecular weight standards (kDa) are indicated. TPA (Fig. 3A) showing that the level of phosphate incorporation into MARCKS remained elevated throughout the 17 and 72 h of TPA treatment. On the other hand, GAP-43 content increased in response to both 17 and 72 h of TPA (Fig. 3B) . The GAP-43 content increased by 2.5-and 3.7-fold in 17 and 72 h TPA-treated cells, respectively, as compared to control, untreated cells ( Table 1 ). The ratio of GAP-43 phosphate levels to GAP-43 content decreased with increasing length of incubation with TPA (Table 1 ) but was signi¢cantly elevated over control levels at both 15 min and 17 h of TPA treatment.
Identi¢cation of phosphorylation sites on GAP-43 and MARCKS
We investigated whether the elevated phosphate labeling of GAP-43 during the 17 and 72 h of TPA treatment was on a peptide fragment containing the PKC site. Digestion of GAP-43 with SAPV8 produces at least three well-characterized peptides. PKC phosphorylates GAP-43 at a single amino acid, serine 41 . The major peptides from SAPV8 digestion migrate on SDS-PAGE at approximately 28 kDa (amino acids 1^132, for the rat protein), 21 kDa (amino acids 133^226) and 15 kDa (amino acids 1^6 5, 66^132) [14] . The human protein is 12 amino acids longer, 9 of which are just amino-terminal to amino acid 132 [24] . Immunoprecipitated 32 P-labeled GAP-43, prepared from cells treated with or without 70 nM TPA for 15 min, 17 and 72 h, was digested with SAPV8 during electrophoresis on a 15% polyacrylamide gel [13] . After treatment with SAPV8, the pattern of phosphopeptides produced was similar for all three TPA treatments (Fig. 4) . In addition to the 45 kDa undigested GAP-43, SAPV8 produced peptides of approximately 28, 21 and 15 kDa. The control sample did not show the presence of a 15 kDa fragment, however, and contained very low levels of radioactivity.
It has previously been demonstrated that the phosphorylation sites on MARCKS protein are virtually identical after either 16 h or 10 min exposure to a high dose (16 WM) of TPA [5] . We used a lower dose of TPA (70 nM) but treated cells for longer times (72 h). Therefore, we examined whether the phos- 32 P] i for 2 h. Vehicle-treated cells were left untreated (Ctrl) or treated with 70 nM TPA for 15 min at 37³C, and PCA-soluble protein was prepared for all conditions as described in Section 2. 15 Wg/lane of PCA-soluble protein was immunoprecipitated with monoclonal anti-GAP-43, and immunoprecipitated protein was separated by 7% SDS-PAGE. Wet gels were wrapped in plastic wrap, exposed to ¢lm, and the bands corresponding to GAP-43 were cut out of the gel. Gel pieces were resuspended in SDS-sample bu¡er and left untreated or digested with 3.3 ng SAPV8 per gel piece during electrophoresis on a 4% stacking and 15% separating gel [13] . Gels were dried and exposed to ¢lm. Molecular weights (kDa) of the 32 P-labeled bands are indicated to the right. phorylation sites of MARCKS induced by long-term TPA treatment of SK-N-SH cells were the same as those induced by short-term (15 min) TPA treatment. PKC phosphorylates MARCKS at 3 serines, all within a 25-amino acid region on MARCKS [20] but other sites are phosphorylated by other kinases [51, 53] . Tryptic phosphopeptides of MARCKS, labeled with [ 32 P] i in cells treated with TPA for 15 min, 17 or 72 h, were subjected to reverse phase HPLC. There were peaks of radioactivity at fraction numbers 5, 28, 40 and 50 for all TPA-treated samples (Fig. 5) . Compared to the control, vehicle-treated sample, peaks at fractions 40 and 50 were increased in all TPA-treated samples. There was signi¢cant basal incorporation of [ 32 P] into MARCKS in untreated cells.
E¡ect of short-and long-term TPA treatment on PKC isozyme content and activity in SK-N-SH cells
Since the phosphorylation of GAP-43 was maintained for 17 h of TPA treatment and MARCKS for 72 h, we analyzed the responsiveness of PKC isozyme content and general activity to acute and long-term TPA. We had found that long-term TPA in SK-N-SH cells down-regulated the K and O isozymes of PKC [46] but did not examine acute e¡ects of TPA. Examination of the vehicle-treated cells in Fig. 6 reveals that only PKC O was translocated from the supernatant to the pellet in response to 15 min of TPA even though both the K and L isozymes of PKC are also sensitive to TPA [28] . The content of both . PCA-soluble protein was prepared as described in Section 2. 15 Wg/lane of PCA-soluble protein was separated by 7% SDS-PAGE, gels were dried, exposed to ¢lm and the bands corresponding to MARCKS cut out of the gel. Gel pieces were rehydrated, digested with trypsin, lyophilized, and subjected to reverse phase HPLC as described. Fractions were collected and radioactivity measured by liquid scintillation counting. Results are expressed as the percentage of total cpm multiplied by 100 for each sample.
PKC K and O in the supernatant was greatly reduced after 17 or 72 h of TPA. However, PKC K in the membrane fraction appeared to be more sensitive to continuous TPA than was membrane-associated PKC O (Fig. 6C) . The membrane fraction of PKC K showed an obvious doublet after 17 and 72 h, perhaps due to a change in phosphorylation state of the enzyme (Fig. 6A) . PKC O migrated as a distinct doublet in both supernatant and membrane fractions. The blots in Fig. 6B ,D distinctly demon- PKC activity assays were performed on 100 000Ug cytosol and membrane fractions from the treated cells using MBP 4À14 as a substrate. The data in Table 2 demonstrate that the 15 min TPA treatment elicited the expected increase in PKC activity in the membrane fraction and a decrease in the supernatant fraction. After 17 or 72 h of 70 nM TPA, the PKC activity in the supernatant fraction was nearly abol-ished. The PKC activity in the membranes was also greatly reduced but at least 23% of the control activity was present after 72 h of TPA.
E¡ect of long-term TPA treatment on the subcellular distribution of GAP-43, PKC K and PKC O
Although it appeared that residual PKC activity in membranes could maintain elevated phosphorylation of MARCKS, phosphorylation of GAP-43 was not elevated concomitant with the increase in content. Two possibilities are that either the entire GAP-43 pool becomes evenly phosphorylated or the newlysynthesized GAP-43 was not being phosphorylated. We examined whether the subcellular distribution of GAP-43 and select PKC isozymes would be parallel or divergent after short-and long-term TPA. Subcellular fractions from vehicle-or TPA-treated cells were immunoblotted for GAP-43, PKC K and PKC O. The data from the immunoblots (Fig. 7A ) of three separate experiments were quanti¢ed and are shown in Fig. 7B . The subcellular distribution of each protein and its response to TPA was unique. GAP-43 was highly concentrated in the P2 fraction in control cells with very low concentrations in the P3 and S3 fractions and its distribution was not altered by 15 min of 70 nM TPA. After 72 h of TPA, however, GAP-43 content was signi¢cantly increased in both the P1 and P2 fractions. PKC O, which was most concentrated in the S3 fraction in untreated cells, translocated from the P3 and S3 fractions to the P2 fraction after 15 min of TPA. After 72 h of TPA, the PKC O in P3 and S3 fractions remained low but the concentration in the P1 and P2 fractions were 60 and 36%, respectively, of those given 15 min of TPA. Although PKC K showed no redistribution after 15 min of TPA its content was evenly reduced in all fractions after 72 h of TPA.
Discussion
Continuous treatment with TPA generally results in decreases in content of select PKC isozymes, PKC activity, phosphorylation of substrate proteins and physiological response to PKC activation [28] . We and others, however, found that phosphorylation of MARCKS is maintained during prolonged TPA treatment in SK-N-SH cells [46] and the subclone SH-SY5Y [38] and 1321 human astrocytoma cells [5] . In this study, we examined whether phosphorylation of another prominent PKC substrate, GAP-43, would be regulated similarly to MARCKS. This is the ¢rst report to investigate the phosphorylation of GAP-43 as a result of persistent PKC activation. Enhanced phosphate levels in GAP-43 were maintained for only 17 h due to increased synthesis of the protein while the enhanced labeling of MARCKS was maintained throughout 72 h of TPA treatment. These results demonstrate that prolonged activation of PKC need not result in a generalized reduction in phosphorylation of PKC substrates and that selective regulation of substrate phosphorylation can occur even with a general activator such as TPA. The fact that the phosphate to protein ratio of GAP-43 Statistical signi¢cance for changes within a speci¢c fraction was determined by a one-way ANOVA with Tukey-Kramer post-test analysis. *Denotes a level of signi¢cant di¡erence. For GAP-43: P1, ANOVA P 6 0.005, 72 h values di¡er from Con and 15 min at P 6 0.01; P2, ANOVA, P 6 0.02, 72 h values di¡er from Con and 15 min at P 6 0.05. For PKC O: P1, ANOVA P 6 0.01, 72 h values di¡er from Con at P 6 0.05, 72 h values di¡er from 15 min at P 6 0.01; P2, ANOVA, P 6 0.005, 15 min values di¡er from Con at P 6 0.05; 72 h values di¡er from 15 min at P 6 0.01; P3, ANOVA P 6 0.02, Con and 15 min vs. 72 h, P 6 0.05; S3 ANOVA, P 6 0.0001, Con and 15 min vs. 72 h, P 6 0.001. For PKC K; all values at 72 h are signi¢cantly di¡erent from Con and 15 min at P 6 0.01. 6 returned to control levels at 72 h suggests that either the newly-synthesized GAP-43 is phosphorylated in response to the continuous TPA or that GAP-43 at a select location is retaining high phosphate levels. Continuous TPA treatment can also lead to cellular di¡erentiation [5, 39] . The enhanced phosphorylation of MARCKS after TPA is a result of the continued presence of TPA rather than cell di¡erentiation per se [39] because MARCKS was not continuously phosphorylated upon di¡erentiation of the cells with retinoic acid [46] .
Long-term treatment with TPA also leads to stable elevated phosphate incorporation into pp60 src and the high molecular weight subunit of neuro¢lament in SH-SY5Y cells [4, 26] and epidermal growth factor receptor in human diploid ¢broblasts [15] . We now report that phosphorylation of GAP-43 is also enhanced after 17 h of TPA. The proteins reported thus far to demonstrate enhanced 32 P-labeling after prolonged TPA are membrane-and/or cytoskeletonbound proteins. PKC-dependent phosphorylation of GAP-43 has been shown to be important for Ca 2 -dependent neurotransmitter release [16] , cell growth and learning [47] and growth cone extension [18] . Phosphorylation of GAP-43 at the PKC substrate site, ser 41 is important for ¢broblast growth factorinduced stimulation of neurite outgrowth in neurites and growth cones [30] . Prolonged phosphorylation of either GAP-43 or MARCKS could have signi¢cant e¡ects on the cell cytoskeleton resulting in altered cell function and motility.
The enhanced 32 P-labeling in MARCKS and GAP-43 could be due to constitutively active PKC. Administration of fresh TPA after 72 h elicited no further enhancement of phosphorylation of MARCKS suggesting that the remaining PKC activity could be constitutive. Our assays showed that as much as 23% of PKC activity and signi¢cant amounts of PKC isozymes remain in membranes after 17 and 72 h of TPA. In support of the concept of a persistently activated PKC, activation of PKC LII [8] and O [42] isozymes by phorbol esters resulted in their binding to the actin cytoskeleton with persistent activation. Prekeris et al. [42] demonstrated that the binding of activated PKC O to actin in the cytoskeleton of hippocampal synaptosomes elicited prolonged activation of an 80 kDa PKC substrate even after the TPA stimulus was washed out. Both MARCKS [10, 21] and GAP-43 [35] can be phosphorylated in vitro by several of the PKC isozymes including LII and O isozymes. The pattern of expression of GAP-43 and PKCLII in vivo are highly similar in nerve endings in the hippocampus [47] and in growth cones [18] .
The isozyme that could be contributing to the enhanced phosphorylating activity after TPA treatment in SK-N-SH cells is unknown, but of the PKC isozymes we examined, PKC O was the most responsive to short-term TPA stimulation. TPA induced a pronounced redistribution of the O isozyme from the soluble and P3 fractions to the P2 fraction and there was a signi¢cant amount of the O isozyme remaining in the membrane fractions after 17 and 72 h of TPA. We and others [23, 26] found that continuous TPA had a greater e¡ect in down-regulating the K isozyme of PKC as compared to the O isozyme in SK-N-SH and SH-SY5Y cells. Based on the subcellular fractionation immunoblots, the PKC O concentration and total content at 72 h of TPA represented 36 and 72%, respectively, of the values attained at 15 min of TPA. The L isoform did not change in response to shortterm TPA, but neither was it down-regulated in response to continuous TPA. Therefore it, too, could be contributing to the enhanced phosphorylation of MARCKS and GAP-43. One cannot discount, however, that altered phosphatase activity is playing a role in our reported increase in 32 P-labeling of GAP-43 and MARCKS.
Enhanced phosphorylation of MARCKS in response to continuous TPA is not a general phenomenon and has been most often reported in human cells. Prolonged TPA decreased MARCKS content in human megakaryoblastic leukemia cells [31] , immortalized rat hippocampal cell line HN33 [52] and mouse Swiss 3T3 ¢broblasts [27] . Similarly, downregulation of PKC activity in rat oligodendrocytes resulted in a total inhibition of GAP-43 phosphorylation [17] . A factor that may contribute to the enhanced phosphorylation and apparent retention of some membrane PKC activity is the metabolism of TPA which may depend upon both the species and the cell type. Human ¢broblasts were largely unable to metabolize TPA while mouse ¢broblasts readily metabolized the phorbol ester. On the other hand, human hepatoma cells did metabolize TPA [34] . If SK-N-SH and SH-SY5Y cells do not metabolize TPA it could remain active for long periods of incubation.
In contrast to MARCKS, enhanced phosphorylation of GAP-43 was maintained only for 17 h. Although labeling of the GAP-43 was still enhanced at 72 h compared to control, the content of GAP-43 was similarly increased. Perrone-Bizzozero et al. [40] have shown that PKC activation stabilized the mRNA of GAP-43 in PC-12 cells, an action which may also be operative in SK-N-SH cells. At 72 h, the ratio of phosphorylated GAP-43 to total GAP-43 was at control levels. It is unclear whether newlysynthesized GAP-43 is becoming phosphorylated or whether the older phosphorylated pool of GAP-43 remains stable and the newly synthesized pool of GAP-43 does not have increased phosphate content. However, because the increase in GAP-43 content is highest in the P1 and P2 fractions, and there is signi¢cant PKC remaining in those fractions, the newlysynthesized GAP-43 could be phosphorylated by remaining PKC activity.
The investigation of the labeled peptides of the digested proteins suggested that PKC activation was responsible, either directly or indirectly, for the enhanced phosphorylation of both GAP-43 and MARCKS. For GAP-43, the pattern of 32 P-labeled peptides produced by SAPV8 digestion (on a 15% gel) was nearly identical for all three lengths of TPA treatment. These results show the presence of 32 P-labeled peptides at 28, 21 and 15 kDa, as well as the 45 kDa undigested protein. The PKC site at serine 41 is contained in the 28 kDa fragment and one of the 15 kDa fragments. Phosphorylation of GAP-43 and MARCKS induced by a 15 min of TPA was completely inhibited by the selective PKC inhibitor Ro31-8220 (Goldsmith and Gnegy, unpublished observation). This suggests that a 15 min treatment with TPA is inducing PKC to phosphorylate GAP-43 in SK-N-SH cells and the same pattern is maintained throughout the 72 h. Because the 21 kDa fragment also had an increased phosphate content, PKC could be activating another protein kinase which phosphorylates GAP-43. The 21 kDa fragment is the correct size for amino acids 133^226 and may contain a non-PKC-phosphorylated site. This fragment contains potential phosphorylation sites for a proline-directed kinase at threonine 172 [48] and casein kinase II at serine 191a192 [41] . The control sample did not show the presence of a 15 kDa fragment after SAPV8 treatment likely due to the substantially lower amount of radioactivity in this sample. The PKC site might not be substantially phosphorylated in control, untreated cells. Regardless, based on the similarity of digestion patterns for all three TPA treatments, we conclude that GAP-43 is being phosphorylated at the same site(s), independent of the length of treatment with TPA. Similarly, the phosphopeptide patterns from trypsin-digested MARCKS were similar whether the cells were treated with TPA for 15 min, 17 or 72 h. The enhanced phosphorylation on two MARCKS fragments (peaks at fractions 40 and 50) in TPA-treated cells compared to untreated cells could re£ect phosphorylation by PKC at both sites or it could re£ect phosphorylation by another kinase that is activated by PKC. TPA-induced phosphorylation by PKC can activate MAP kinase in SH-SY5Y cells [36] . Recently, p42 MAP kinase has been shown to phosphorylate MARCKS at ser 113 in vitro [45] . MARCKS is a substrate for at least two other types of protein kinases, proline-directed kinases [51, 53] and PKC-related kinase-1 (PRK1), which phosphorylates MARCKS at the same sites as PKC [37] . It is not known whether PRK1 can be activated by PKC.
In summary, we report a maintenance of phosphorylation of MARCKS and GAP-43 in SK-N-SH cells after long-term TPA treatment. Our results would suggest that MARCKS and GAP-43 can be phosphorylated by PKC isozymes that remain active in membrane fractions during the continuous TPA. Enhanced GAP-43 synthesis, however, in response to 72 h of TPA appeared to balance out the elevation in 32 P-incorporation. Therefore, prolonged PKC stimulation may maintain phosphorylation of some substrates depending on their subcellular location, the type of PKC isozymes and perhaps the metabolism of TPA itself.
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